Combining Ribavirin with Interferon has been found to be more effective than Interferon monotherapy in the treatment of chronic hepatitis C. In a large clinical trial of 1121 patients, a sustained virological response (SVR) was achieved in 53% of patients treated with Interferon plus Ribavirin as compared to 29% of patients treated with Interferon alone1, 4.